Clinical trials
Fatty Liver trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 3 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2015 | 3 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 3 |
| 2023 | 2 |
| 2024 | 4 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Recruiting | 6 |
| Active, not recruiting | 3 |
| Terminated | 3 |
| Unknown status | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| 89bio, Inc. | 2 |
| German Diabetes Center | 2 |
| Sanofi | 2 |
| Abbott | 1 |
| AstraZeneca | 1 |
| Eli Lilly and Company | 1 |
| Enanta Pharmaceuticals, Inc | 1 |
| Endra Lifesciences | 1 |
| Galmed Research and Development, Ltd. | 1 |
| GlaxoSmithKline | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fatty Liver | 25 |
| Non-alcoholic Fatty Liver Disease | 17 |
| Fibrosis | 6 |
| Liver Cirrhosis | 6 |
| Diabetes Mellitus, Type 2 | 5 |
| Liver Diseases | 4 |
| Obesity | 4 |
| Digestive System Diseases | 3 |
| Insulin Resistance | 3 |
| Diabetes Mellitus | 2 |
Trials
Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.